Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis - PubMed (original) (raw)
Review
. 2020 Sep-Oct;19(5):451-457.
doi: 10.1016/j.aohep.2020.04.010. Epub 2020 Jun 6.
Affiliations
- PMID: 32533951
- DOI: 10.1016/j.aohep.2020.04.010
Free article
Review
Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
Angelo A Mattos et al. Ann Hepatol. 2020 Sep-Oct.
Free article
Abstract
Infections are a frequent complication and a major cause of death among patients with cirrhosis. The important impact of infections in general and especially spontaneous bacterial peritonitis on the course of disease and prognosis of patients with cirrhosis has been recognized for many years. Nevertheless, such importance has recently increased due to the comprehension of infection as one of the most prominent risk factors for patients to develop acute-on-chronic liver failure. Furthermore, the issue of infections in cirrhosis is a focus of increasing attention because of the spreading of multidrug resistant bacteria, which is an emerging concern among physicians assisting patients with cirrhosis. In the present paper, we will review the current epidemiology of infections in patients with cirrhosis and particularly that of infections caused by resistant bacteria, demonstrating the relevance of the subject. Besides, we will discuss the current recommendations on diagnosis and treatment of different kinds of infections, including spontaneous bacterial peritonitis, and we will highlight the importance of knowing local microbiological profiles and choosing empirical antibiotic therapy wisely. Finally, we will debate the existing evidences regarding the role of volume expansion with albumin in patients with cirrhosis and extraperitoneal infections, and that of antibiotic prophylaxis of spontaneous bacterial peritonitis.
Keywords: Antibiotics; Cirrhosis; Infection; Multidrug-resistant bacteria; Spontaneous bacterial peritonitis.
Copyright © 2020 Fundación Clínica Médica Sur, A.C. Published by Elsevier España, S.L.U. All rights reserved.
Similar articles
- Multi-resistant bacteria in spontaneous bacterial peritonitis: a new step in management?
de Mattos AA, Costabeber AM, Lionço LC, Tovo CV. de Mattos AA, et al. World J Gastroenterol. 2014 Oct 21;20(39):14079-86. doi: 10.3748/wjg.v20.i39.14079. World J Gastroenterol. 2014. PMID: 25339797 Free PMC article. Review. - Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia.
Alexopoulou A, Vasilieva L, Agiasotelli D, Siranidi K, Pouriki S, Tsiriga A, Toutouza M, Dourakis SP. Alexopoulou A, et al. World J Gastroenterol. 2016 Apr 21;22(15):4049-56. doi: 10.3748/wjg.v22.i15.4049. World J Gastroenterol. 2016. PMID: 27099449 Free PMC article. - Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: implications for management and prognosis.
Friedrich K, Nüssle S, Rehlen T, Stremmel W, Mischnik A, Eisenbach C. Friedrich K, et al. J Gastroenterol Hepatol. 2016 Jun;31(6):1191-5. doi: 10.1111/jgh.13266. J Gastroenterol Hepatol. 2016. PMID: 26676553 - Effect of 4% gelofusine plus antibiotics on renal impairment and mortality in high-risk cirrhotic patients with spontaneous bacterial peritonitis.
Sirinthornpunya S, Luangvichcharoen K. Sirinthornpunya S, et al. J Med Assoc Thai. 2013 Mar;96 Suppl 3:S77-83. J Med Assoc Thai. 2013. PMID: 23682527 - Review article: spontaneous bacterial peritonitis--diagnosis, treatment and prevention.
Mowat C, Stanley AJ. Mowat C, et al. Aliment Pharmacol Ther. 2001 Dec;15(12):1851-9. doi: 10.1046/j.1365-2036.2001.01116.x. Aliment Pharmacol Ther. 2001. PMID: 11736714 Review.
Cited by
- Diabetes mellitus and the risk of spontaneous bacterial peritonitis in patients with liver cirrhosis: a systematic review and meta-analysis.
Alhajaji R, Samkari MM, Althobaiti MA, Al-Ahmadi BR, Bugis AM, Bugis AM, Sabbagh FY, Althobaiti SA, Bukari AS, Alqurashi SM, Mshrai HA, Abdelwahab OA. Alhajaji R, et al. Ann Saudi Med. 2024 Jul-Aug;44(4):272-287. doi: 10.5144/0256-4947.2024.272. Epub 2024 Aug 1. Ann Saudi Med. 2024. PMID: 39127903 Free PMC article. Review. - Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: A Pilot Trial (AMBIC).
Rusticeanu MA, Zimmer V. Rusticeanu MA, et al. Diagnostics (Basel). 2024 Jul 25;14(15):1606. doi: 10.3390/diagnostics14151606. Diagnostics (Basel). 2024. PMID: 39125482 Free PMC article. - Severe insulin resistance in a patient with diabetes after treatment with brentuximab vedotin.
Peeters G, Verhaegen A. Peeters G, et al. BMJ Case Rep. 2024 Apr 2;17(4):e251867. doi: 10.1136/bcr-2022-251867. BMJ Case Rep. 2024. PMID: 38569738 - Comparative Analysis of Demographic and Clinical Findings in Spontaneous, Peritoneal Dialysis-Related, and Secondary Bacterial Peritonitis.
Unver Ulusoy T, Karakoç Parlayan HN, Altın N, Sarıkaya B, Öztürk B, Şencan İ. Unver Ulusoy T, et al. Cureus. 2024 Mar 3;16(3):e55445. doi: 10.7759/cureus.55445. eCollection 2024 Mar. Cureus. 2024. PMID: 38567242 Free PMC article. - Comparison of Rifaximin Alone and With Quinolones in the Primary Prevention of Spontaneous Bacterial Peritonitis in Patients With Decompensated Chronic Liver Disease.
Zaman T, Ahmed Attari MB, Ahmad A, Butt MA, Fayyaz K, Zubair SA. Zaman T, et al. Cureus. 2024 Feb 29;16(2):e55251. doi: 10.7759/cureus.55251. eCollection 2024 Feb. Cureus. 2024. PMID: 38558603 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical